Trials / Unknown
UnknownNCT04942873
The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
Study of Compliance and Influencing Factors in Chinese Patients With Nonvalvular Atrial Fibrillation (NVAF) to Oral Anticoagulant
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Investigate the compliance of oral anticoagulants in Chinese NVAF patients and find out the causes, so as to provide basis for formulating effective measures to improve the compliance of oral anticoagulants.
Detailed description
1. The general information about these patients was recorded such as gender, age, smoking history, drinking history, heart failure, hypertension, diabetes, coronary heart disease, stroke history, TIA history, peripheral vascular disease, etc. CHA2DS2-VASc score and HAS-BLED score were recorded. 2. Medication information and follow-up information was collected.For the patients included in the study, the medication records of oral anticoagulants (outpatient, emergency, hospitalization), adverse reactions, anticoagulant use history, drug withdrawal or dressing change, disease changes, etc. within three years were recorded by referring to the patient's medical records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | adherence | PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran, rivaroxaban and wafarin |
Timeline
- Start date
- 2021-07-20
- Primary completion
- 2022-06-06
- Completion
- 2023-06-10
- First posted
- 2021-06-29
- Last updated
- 2021-06-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04942873. Inclusion in this directory is not an endorsement.